In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 286946-24-5, name is Methyl 3,6-dichloropyridazine-4-carboxylate, introducing its new discovery. SDS of cas: 286946-24-5
Pyridinone and Pyridazinone Derivatives
The present invention provides for compounds of formula (I) wherein A1, A2, A3, A4, J, and X3 have any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, diabetes, obesity, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula I.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 286946-24-5, and how the biochemistry of the body works.SDS of cas: 286946-24-5
Reference£º
Pyridazine – Wikipedia,
Pyridazine | C4H4N2896 – PubChem